Higher-dose brain stimulation for depression is well tolerated in small pilot study
Marom Bikson
Marom Bikson and colleagues tested whether people with major depression could tolerate a stronger, faster course of transcranial direct current stimulation, which passes a weak electrical current through electrodes on the head. A home-based 2 mA version was recently approved by the US Food and Drug Administration for depression, but skin discomfort has limited higher currents. Using a high-capacity stimulator and hydrogel electrodes, the team gave 20 patients 20-minute sessions at 6 mA, twice a day for five days. All 203 sessions were completed, and 19 of 20 people tolerated the full dose. There were no serious adverse events. Everyone had skin redness at the electrodes, with no severe reactions. Depression scores fell by more than half, though the study had no placebo comparison. The researchers say a trial comparing it with a sham treatment is warranted. The study, posted on medRxiv, has not yet been peer reviewed.
Accelerated high-capacity 6 mA transcranial direct current stimulation for major depression: an open-label pilot study. medRxiv, 2026. Preprint, not yet peer reviewed